A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

Inclusion Criteria: * Has a diagnosis and stable medical management (for at least 3 months) of one of the following risk conditions for pneumococcal disease: Diabetes mellitus, chronic compensated liver disease, chronic lung disease, chronic heart disease, or chronic kidney disease. * Has completed pneumococcal conjugate vaccine regimen (PCV7, PCV10, or PCV13) at least 8 weeks before study enrollment. Exclusion Criteria: * Had a curative procedure/surgery for chronic heart disease and does not require medication, follow-up, additional interventions, or further management per local guidelines. * Has a history of active hepatitis within 3 months before study vaccination. * Has a history of diabetic ketoacidosis or 2 or more episodes of severe, symptomatic hypoglycemia within 3 months before study vaccination. * Has a history of severely decreased kidney function dialysis, autoimmune related chronic kidney disease, nephrotic syndrome of any cause, or an acute/reversible cause of kidney disease. * Has a history of severe pulmonary hypertension or history of Eisenmenger syndrome. * History of invasive pneumococcal disease within 3 years before study vaccination.